Loading clinical trials...
Loading clinical trials...
Artemisinin combination therapies (ACT) are currently recommended for malaria treatment. Artemether-lumefantrine(A-L) and Artesunate+amodiaquine (A+A) have been the most commonly adopted of the recomm...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Ghana Medical School
Collaborators
NCT07403643 · Uncomplicated Malaria
NCT04767217 · Uncomplicated Malaria
NCT04767191 · Uncomplicated Malaria
NCT06036030 · Malaria,Falciparum, Malaria, Vivax, and more
NCT01213433 · Uncomplicated Malaria
Korle Bu Teaching Hospital
Accra
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions